CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status ...
Q3 2025 Earnings Call Transcript October 28, 2025 Incyte Corporation beats earnings expectations. Reported EPS is $2.11, ...
The Apache Software Foundation disputes claims that its OpenOffice project suffered an Akira ransomware attack, after the ...
The Open VSX registry rotated access tokens after they were accidentally leaked by developers in public repositories and allowed threat actors to publish malicious extensions in an attempted ...
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that results from the Phase III ...
Thank you, operator. Good morning and good afternoon, everybody, and thank you for joining BioNTech's Third Quarter 2025 Earnings Call. As a reminder, the slides we'll use during the call and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback